2010
DOI: 10.1016/j.addr.2009.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Structural and chemical aspects of HPMA copolymers as drug carriers☆

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
154
0
4

Year Published

2011
2011
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 181 publications
(161 citation statements)
references
References 193 publications
0
154
0
4
Order By: Relevance
“…One promising compound fulfilling these requirements is poly-N-(2-hydroxypropyl)methacrylamide (p [HPMA]) polymers that have been already tested in preclinical as well as clinical studies. [7][8][9] Further development of these hydrophilic N-(2-hydroxypropyl)methacrylamide (HPMA) homopolymers led to the design of copolymers containing lipophilic lauryl methacrylate (LMA) segments within the HPMA backbone. These HPMA-LMA copolymers (p(HPMA)-co-p(LMA) and p(HPMA)-b-p(LMA) copolymers) have been shown to improve the drug transport through the blood-brain barrier.…”
Section: Introductionmentioning
confidence: 99%
“…One promising compound fulfilling these requirements is poly-N-(2-hydroxypropyl)methacrylamide (p [HPMA]) polymers that have been already tested in preclinical as well as clinical studies. [7][8][9] Further development of these hydrophilic N-(2-hydroxypropyl)methacrylamide (HPMA) homopolymers led to the design of copolymers containing lipophilic lauryl methacrylate (LMA) segments within the HPMA backbone. These HPMA-LMA copolymers (p(HPMA)-co-p(LMA) and p(HPMA)-b-p(LMA) copolymers) have been shown to improve the drug transport through the blood-brain barrier.…”
Section: Introductionmentioning
confidence: 99%
“…Poly-N-(2-hydroxypropyl) methacrylamide, pHPMA, is a neutral and biocompatible polymeric carrier used to prepare different soluble drug conjugates with a high residence time in plasma and low tissue distribution compared to other polymer systems [1][2][3][4][5]. Because of this well-known performance in physiological media, this neutral polymer has been studied for more than a decade as sterical stabilizer of polycation-DNA complexes or polyplexes, in order to modulate their positive charge density and hydrophilia, in an attempt to avoid nonspecific interactions with both the cellular membrane and plasma components.…”
Section: Introductionmentioning
confidence: 99%
“…[23,24] The choice of an appropriate polymeric carrier is crucial for systemic administration and 2-hydroxypropyl methacrylamide (HPMA)-based polymers have drawn special attention. [25,26] The linear or branched polymer chain usually serves as the structural component of a conjugate. Most of the clinically tested polymer conjugates have the typical structure consisting of a polymer backbone, a linker and the bioactive unit.…”
Section: Introductionmentioning
confidence: 99%